Baidu
map
IEEE T IMAGE PROCESS 润色咨询

IEEE TRANSACTIONS ON IMAGE PROCESSING

出版年份:暂无数据 年文章数:7270 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:12.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1091652, encodeId=753c1091652ba, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091651, encodeId=6c00109165133, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857043, encodeId=42cc85e04380, content=审稿速度:7.0<br>经验分享:2019.6.8—2019.10.23 一审,major revision;<br> 2019.10.23—2019.11.30 修改论文<br> 2019.11.30—2020.1.2 二审,accepted with mandatory revisions;<br> 2020.1.2—2020.1.7 修改论文;<br> 2020.1.7—2020.1.20 accept.<br> 审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Wed Jan 22 11:41:09 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856666, encodeId=a5a88566667c, content=2018年6月投稿;<br> 2019年2月一审意见rq;<br> 2019年4月修回;<br> 2019年8月二审意见rq;<br> 2019年10月修回;<br> 2020年1月三审意见reject。<br> 共历时将近19个月,最终被拒。<br> 审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。<br> 伤心的同时,也对该期刊的严谨和认真表示钦佩。<br> 创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Thu Jan 09 14:07:25 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856182, encodeId=a66d856182b5, content=tip终于上中科院一区了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Wed Dec 25 10:47:37 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855535, encodeId=cc8585553506, content=审稿速度:8.0<br>经验分享:2017.8.25: 投稿<br> 2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;<br> 2018.4.22: 返修提交<br> 2018.8.10: 录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Wed Dec 04 15:27:23 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852440, encodeId=6c5985244062, content=审稿速度:12.0<br>经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。<br> 2018.04.16 submitted<br> 2018.05.18 in peer review,区域编辑初审,未分配副主编<br> 2018.06.11 submitted (区域编辑同意送审)<br> 2018.07.02 in peer review,已分配副主编<br> 2018.10.21 awaiting ae decision<br> 2018.10.25 major revision (due 2018.12.05)<br> 2018.12.02提交大修版本,状态直接变为in peer review<br> 2019.04.18 awaiting ae decision<br> 2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)<br> 2019.04.22提交小修版本,状态直接变为in peer review<br> 2019.07.06 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Sun Jul 07 15:21:58 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851003, encodeId=d6bd851003cf, content=什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Apr 24 12:05:33 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850848, encodeId=ce6a85084877, content=看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Tue Apr 16 18:49:43 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847864, encodeId=428f84e8647a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Oct 25 17:08:11 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2021-12-27 乌云背后的幸福线

    如何判断两种药物之间是协同作用还是相加作用?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1091652, encodeId=753c1091652ba, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091651, encodeId=6c00109165133, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857043, encodeId=42cc85e04380, content=审稿速度:7.0<br>经验分享:2019.6.8—2019.10.23 一审,major revision;<br> 2019.10.23—2019.11.30 修改论文<br> 2019.11.30—2020.1.2 二审,accepted with mandatory revisions;<br> 2020.1.2—2020.1.7 修改论文;<br> 2020.1.7—2020.1.20 accept.<br> 审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Wed Jan 22 11:41:09 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856666, encodeId=a5a88566667c, content=2018年6月投稿;<br> 2019年2月一审意见rq;<br> 2019年4月修回;<br> 2019年8月二审意见rq;<br> 2019年10月修回;<br> 2020年1月三审意见reject。<br> 共历时将近19个月,最终被拒。<br> 审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。<br> 伤心的同时,也对该期刊的严谨和认真表示钦佩。<br> 创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Thu Jan 09 14:07:25 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856182, encodeId=a66d856182b5, content=tip终于上中科院一区了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Wed Dec 25 10:47:37 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855535, encodeId=cc8585553506, content=审稿速度:8.0<br>经验分享:2017.8.25: 投稿<br> 2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;<br> 2018.4.22: 返修提交<br> 2018.8.10: 录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Wed Dec 04 15:27:23 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852440, encodeId=6c5985244062, content=审稿速度:12.0<br>经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。<br> 2018.04.16 submitted<br> 2018.05.18 in peer review,区域编辑初审,未分配副主编<br> 2018.06.11 submitted (区域编辑同意送审)<br> 2018.07.02 in peer review,已分配副主编<br> 2018.10.21 awaiting ae decision<br> 2018.10.25 major revision (due 2018.12.05)<br> 2018.12.02提交大修版本,状态直接变为in peer review<br> 2019.04.18 awaiting ae decision<br> 2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)<br> 2019.04.22提交小修版本,状态直接变为in peer review<br> 2019.07.06 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Sun Jul 07 15:21:58 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851003, encodeId=d6bd851003cf, content=什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Apr 24 12:05:33 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850848, encodeId=ce6a85084877, content=看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Tue Apr 16 18:49:43 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847864, encodeId=428f84e8647a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Oct 25 17:08:11 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2021-12-27 rayms

    上传文章有什么要求?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1091652, encodeId=753c1091652ba, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091651, encodeId=6c00109165133, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857043, encodeId=42cc85e04380, content=审稿速度:7.0<br>经验分享:2019.6.8—2019.10.23 一审,major revision;<br> 2019.10.23—2019.11.30 修改论文<br> 2019.11.30—2020.1.2 二审,accepted with mandatory revisions;<br> 2020.1.2—2020.1.7 修改论文;<br> 2020.1.7—2020.1.20 accept.<br> 审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Wed Jan 22 11:41:09 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856666, encodeId=a5a88566667c, content=2018年6月投稿;<br> 2019年2月一审意见rq;<br> 2019年4月修回;<br> 2019年8月二审意见rq;<br> 2019年10月修回;<br> 2020年1月三审意见reject。<br> 共历时将近19个月,最终被拒。<br> 审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。<br> 伤心的同时,也对该期刊的严谨和认真表示钦佩。<br> 创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Thu Jan 09 14:07:25 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856182, encodeId=a66d856182b5, content=tip终于上中科院一区了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Wed Dec 25 10:47:37 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855535, encodeId=cc8585553506, content=审稿速度:8.0<br>经验分享:2017.8.25: 投稿<br> 2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;<br> 2018.4.22: 返修提交<br> 2018.8.10: 录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Wed Dec 04 15:27:23 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852440, encodeId=6c5985244062, content=审稿速度:12.0<br>经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。<br> 2018.04.16 submitted<br> 2018.05.18 in peer review,区域编辑初审,未分配副主编<br> 2018.06.11 submitted (区域编辑同意送审)<br> 2018.07.02 in peer review,已分配副主编<br> 2018.10.21 awaiting ae decision<br> 2018.10.25 major revision (due 2018.12.05)<br> 2018.12.02提交大修版本,状态直接变为in peer review<br> 2019.04.18 awaiting ae decision<br> 2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)<br> 2019.04.22提交小修版本,状态直接变为in peer review<br> 2019.07.06 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Sun Jul 07 15:21:58 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851003, encodeId=d6bd851003cf, content=什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Apr 24 12:05:33 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850848, encodeId=ce6a85084877, content=看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Tue Apr 16 18:49:43 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847864, encodeId=428f84e8647a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Oct 25 17:08:11 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2020-01-22 ms5534528927444041

    审稿速度:7.0
    经验分享:2019.6.8—2019.10.23 一审,major revision;
    2019.10.23—2019.11.30 修改论文
    2019.11.30—2020.1.2 二审,accepted with mandatory revisions;
    2020.1.2—2020.1.7 修改论文;
    2020.1.7—2020.1.20 accept.
    审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1091652, encodeId=753c1091652ba, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091651, encodeId=6c00109165133, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857043, encodeId=42cc85e04380, content=审稿速度:7.0<br>经验分享:2019.6.8—2019.10.23 一审,major revision;<br> 2019.10.23—2019.11.30 修改论文<br> 2019.11.30—2020.1.2 二审,accepted with mandatory revisions;<br> 2020.1.2—2020.1.7 修改论文;<br> 2020.1.7—2020.1.20 accept.<br> 审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Wed Jan 22 11:41:09 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856666, encodeId=a5a88566667c, content=2018年6月投稿;<br> 2019年2月一审意见rq;<br> 2019年4月修回;<br> 2019年8月二审意见rq;<br> 2019年10月修回;<br> 2020年1月三审意见reject。<br> 共历时将近19个月,最终被拒。<br> 审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。<br> 伤心的同时,也对该期刊的严谨和认真表示钦佩。<br> 创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Thu Jan 09 14:07:25 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856182, encodeId=a66d856182b5, content=tip终于上中科院一区了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Wed Dec 25 10:47:37 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855535, encodeId=cc8585553506, content=审稿速度:8.0<br>经验分享:2017.8.25: 投稿<br> 2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;<br> 2018.4.22: 返修提交<br> 2018.8.10: 录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Wed Dec 04 15:27:23 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852440, encodeId=6c5985244062, content=审稿速度:12.0<br>经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。<br> 2018.04.16 submitted<br> 2018.05.18 in peer review,区域编辑初审,未分配副主编<br> 2018.06.11 submitted (区域编辑同意送审)<br> 2018.07.02 in peer review,已分配副主编<br> 2018.10.21 awaiting ae decision<br> 2018.10.25 major revision (due 2018.12.05)<br> 2018.12.02提交大修版本,状态直接变为in peer review<br> 2019.04.18 awaiting ae decision<br> 2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)<br> 2019.04.22提交小修版本,状态直接变为in peer review<br> 2019.07.06 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Sun Jul 07 15:21:58 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851003, encodeId=d6bd851003cf, content=什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Apr 24 12:05:33 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850848, encodeId=ce6a85084877, content=看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Tue Apr 16 18:49:43 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847864, encodeId=428f84e8647a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Oct 25 17:08:11 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2020-01-09 ms3000046594999774

    2018年6月投稿;
    2019年2月一审意见rq;
    2019年4月修回;
    2019年8月二审意见rq;
    2019年10月修回;
    2020年1月三审意见reject。
    共历时将近19个月,最终被拒。
    审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。
    伤心的同时,也对该期刊的严谨和认真表示钦佩。
    创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1091652, encodeId=753c1091652ba, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091651, encodeId=6c00109165133, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857043, encodeId=42cc85e04380, content=审稿速度:7.0<br>经验分享:2019.6.8—2019.10.23 一审,major revision;<br> 2019.10.23—2019.11.30 修改论文<br> 2019.11.30—2020.1.2 二审,accepted with mandatory revisions;<br> 2020.1.2—2020.1.7 修改论文;<br> 2020.1.7—2020.1.20 accept.<br> 审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Wed Jan 22 11:41:09 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856666, encodeId=a5a88566667c, content=2018年6月投稿;<br> 2019年2月一审意见rq;<br> 2019年4月修回;<br> 2019年8月二审意见rq;<br> 2019年10月修回;<br> 2020年1月三审意见reject。<br> 共历时将近19个月,最终被拒。<br> 审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。<br> 伤心的同时,也对该期刊的严谨和认真表示钦佩。<br> 创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Thu Jan 09 14:07:25 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856182, encodeId=a66d856182b5, content=tip终于上中科院一区了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Wed Dec 25 10:47:37 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855535, encodeId=cc8585553506, content=审稿速度:8.0<br>经验分享:2017.8.25: 投稿<br> 2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;<br> 2018.4.22: 返修提交<br> 2018.8.10: 录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Wed Dec 04 15:27:23 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852440, encodeId=6c5985244062, content=审稿速度:12.0<br>经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。<br> 2018.04.16 submitted<br> 2018.05.18 in peer review,区域编辑初审,未分配副主编<br> 2018.06.11 submitted (区域编辑同意送审)<br> 2018.07.02 in peer review,已分配副主编<br> 2018.10.21 awaiting ae decision<br> 2018.10.25 major revision (due 2018.12.05)<br> 2018.12.02提交大修版本,状态直接变为in peer review<br> 2019.04.18 awaiting ae decision<br> 2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)<br> 2019.04.22提交小修版本,状态直接变为in peer review<br> 2019.07.06 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Sun Jul 07 15:21:58 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851003, encodeId=d6bd851003cf, content=什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Apr 24 12:05:33 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850848, encodeId=ce6a85084877, content=看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Tue Apr 16 18:49:43 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847864, encodeId=428f84e8647a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Oct 25 17:08:11 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2019-12-25 ms1560573802851675

    tip终于上中科院一区了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1091652, encodeId=753c1091652ba, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091651, encodeId=6c00109165133, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857043, encodeId=42cc85e04380, content=审稿速度:7.0<br>经验分享:2019.6.8—2019.10.23 一审,major revision;<br> 2019.10.23—2019.11.30 修改论文<br> 2019.11.30—2020.1.2 二审,accepted with mandatory revisions;<br> 2020.1.2—2020.1.7 修改论文;<br> 2020.1.7—2020.1.20 accept.<br> 审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Wed Jan 22 11:41:09 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856666, encodeId=a5a88566667c, content=2018年6月投稿;<br> 2019年2月一审意见rq;<br> 2019年4月修回;<br> 2019年8月二审意见rq;<br> 2019年10月修回;<br> 2020年1月三审意见reject。<br> 共历时将近19个月,最终被拒。<br> 审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。<br> 伤心的同时,也对该期刊的严谨和认真表示钦佩。<br> 创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Thu Jan 09 14:07:25 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856182, encodeId=a66d856182b5, content=tip终于上中科院一区了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Wed Dec 25 10:47:37 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855535, encodeId=cc8585553506, content=审稿速度:8.0<br>经验分享:2017.8.25: 投稿<br> 2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;<br> 2018.4.22: 返修提交<br> 2018.8.10: 录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Wed Dec 04 15:27:23 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852440, encodeId=6c5985244062, content=审稿速度:12.0<br>经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。<br> 2018.04.16 submitted<br> 2018.05.18 in peer review,区域编辑初审,未分配副主编<br> 2018.06.11 submitted (区域编辑同意送审)<br> 2018.07.02 in peer review,已分配副主编<br> 2018.10.21 awaiting ae decision<br> 2018.10.25 major revision (due 2018.12.05)<br> 2018.12.02提交大修版本,状态直接变为in peer review<br> 2019.04.18 awaiting ae decision<br> 2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)<br> 2019.04.22提交小修版本,状态直接变为in peer review<br> 2019.07.06 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Sun Jul 07 15:21:58 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851003, encodeId=d6bd851003cf, content=什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Apr 24 12:05:33 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850848, encodeId=ce6a85084877, content=看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Tue Apr 16 18:49:43 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847864, encodeId=428f84e8647a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Oct 25 17:08:11 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2019-12-04 ms3041982178615389

    审稿速度:8.0
    经验分享:2017.8.25: 投稿
    2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;
    2018.4.22: 返修提交
    2018.8.10: 录用

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1091652, encodeId=753c1091652ba, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091651, encodeId=6c00109165133, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857043, encodeId=42cc85e04380, content=审稿速度:7.0<br>经验分享:2019.6.8—2019.10.23 一审,major revision;<br> 2019.10.23—2019.11.30 修改论文<br> 2019.11.30—2020.1.2 二审,accepted with mandatory revisions;<br> 2020.1.2—2020.1.7 修改论文;<br> 2020.1.7—2020.1.20 accept.<br> 审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Wed Jan 22 11:41:09 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856666, encodeId=a5a88566667c, content=2018年6月投稿;<br> 2019年2月一审意见rq;<br> 2019年4月修回;<br> 2019年8月二审意见rq;<br> 2019年10月修回;<br> 2020年1月三审意见reject。<br> 共历时将近19个月,最终被拒。<br> 审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。<br> 伤心的同时,也对该期刊的严谨和认真表示钦佩。<br> 创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Thu Jan 09 14:07:25 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856182, encodeId=a66d856182b5, content=tip终于上中科院一区了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Wed Dec 25 10:47:37 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855535, encodeId=cc8585553506, content=审稿速度:8.0<br>经验分享:2017.8.25: 投稿<br> 2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;<br> 2018.4.22: 返修提交<br> 2018.8.10: 录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Wed Dec 04 15:27:23 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852440, encodeId=6c5985244062, content=审稿速度:12.0<br>经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。<br> 2018.04.16 submitted<br> 2018.05.18 in peer review,区域编辑初审,未分配副主编<br> 2018.06.11 submitted (区域编辑同意送审)<br> 2018.07.02 in peer review,已分配副主编<br> 2018.10.21 awaiting ae decision<br> 2018.10.25 major revision (due 2018.12.05)<br> 2018.12.02提交大修版本,状态直接变为in peer review<br> 2019.04.18 awaiting ae decision<br> 2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)<br> 2019.04.22提交小修版本,状态直接变为in peer review<br> 2019.07.06 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Sun Jul 07 15:21:58 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851003, encodeId=d6bd851003cf, content=什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Apr 24 12:05:33 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850848, encodeId=ce6a85084877, content=看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Tue Apr 16 18:49:43 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847864, encodeId=428f84e8647a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Oct 25 17:08:11 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2019-07-07 ms1562262113729736

    审稿速度:12.0
    经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。
    2018.04.16 submitted
    2018.05.18 in peer review,区域编辑初审,未分配副主编
    2018.06.11 submitted (区域编辑同意送审)
    2018.07.02 in peer review,已分配副主编
    2018.10.21 awaiting ae decision
    2018.10.25 major revision (due 2018.12.05)
    2018.12.02提交大修版本,状态直接变为in peer review
    2019.04.18 awaiting ae decision
    2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)
    2019.04.22提交小修版本,状态直接变为in peer review
    2019.07.06 accept

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1091652, encodeId=753c1091652ba, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091651, encodeId=6c00109165133, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857043, encodeId=42cc85e04380, content=审稿速度:7.0<br>经验分享:2019.6.8—2019.10.23 一审,major revision;<br> 2019.10.23—2019.11.30 修改论文<br> 2019.11.30—2020.1.2 二审,accepted with mandatory revisions;<br> 2020.1.2—2020.1.7 修改论文;<br> 2020.1.7—2020.1.20 accept.<br> 审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Wed Jan 22 11:41:09 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856666, encodeId=a5a88566667c, content=2018年6月投稿;<br> 2019年2月一审意见rq;<br> 2019年4月修回;<br> 2019年8月二审意见rq;<br> 2019年10月修回;<br> 2020年1月三审意见reject。<br> 共历时将近19个月,最终被拒。<br> 审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。<br> 伤心的同时,也对该期刊的严谨和认真表示钦佩。<br> 创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Thu Jan 09 14:07:25 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856182, encodeId=a66d856182b5, content=tip终于上中科院一区了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Wed Dec 25 10:47:37 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855535, encodeId=cc8585553506, content=审稿速度:8.0<br>经验分享:2017.8.25: 投稿<br> 2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;<br> 2018.4.22: 返修提交<br> 2018.8.10: 录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Wed Dec 04 15:27:23 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852440, encodeId=6c5985244062, content=审稿速度:12.0<br>经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。<br> 2018.04.16 submitted<br> 2018.05.18 in peer review,区域编辑初审,未分配副主编<br> 2018.06.11 submitted (区域编辑同意送审)<br> 2018.07.02 in peer review,已分配副主编<br> 2018.10.21 awaiting ae decision<br> 2018.10.25 major revision (due 2018.12.05)<br> 2018.12.02提交大修版本,状态直接变为in peer review<br> 2019.04.18 awaiting ae decision<br> 2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)<br> 2019.04.22提交小修版本,状态直接变为in peer review<br> 2019.07.06 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Sun Jul 07 15:21:58 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851003, encodeId=d6bd851003cf, content=什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Apr 24 12:05:33 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850848, encodeId=ce6a85084877, content=看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Tue Apr 16 18:49:43 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847864, encodeId=428f84e8647a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Oct 25 17:08:11 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2019-04-24 ms3309476956082021

    什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1091652, encodeId=753c1091652ba, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091651, encodeId=6c00109165133, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857043, encodeId=42cc85e04380, content=审稿速度:7.0<br>经验分享:2019.6.8—2019.10.23 一审,major revision;<br> 2019.10.23—2019.11.30 修改论文<br> 2019.11.30—2020.1.2 二审,accepted with mandatory revisions;<br> 2020.1.2—2020.1.7 修改论文;<br> 2020.1.7—2020.1.20 accept.<br> 审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Wed Jan 22 11:41:09 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856666, encodeId=a5a88566667c, content=2018年6月投稿;<br> 2019年2月一审意见rq;<br> 2019年4月修回;<br> 2019年8月二审意见rq;<br> 2019年10月修回;<br> 2020年1月三审意见reject。<br> 共历时将近19个月,最终被拒。<br> 审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。<br> 伤心的同时,也对该期刊的严谨和认真表示钦佩。<br> 创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Thu Jan 09 14:07:25 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856182, encodeId=a66d856182b5, content=tip终于上中科院一区了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Wed Dec 25 10:47:37 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855535, encodeId=cc8585553506, content=审稿速度:8.0<br>经验分享:2017.8.25: 投稿<br> 2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;<br> 2018.4.22: 返修提交<br> 2018.8.10: 录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Wed Dec 04 15:27:23 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852440, encodeId=6c5985244062, content=审稿速度:12.0<br>经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。<br> 2018.04.16 submitted<br> 2018.05.18 in peer review,区域编辑初审,未分配副主编<br> 2018.06.11 submitted (区域编辑同意送审)<br> 2018.07.02 in peer review,已分配副主编<br> 2018.10.21 awaiting ae decision<br> 2018.10.25 major revision (due 2018.12.05)<br> 2018.12.02提交大修版本,状态直接变为in peer review<br> 2019.04.18 awaiting ae decision<br> 2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)<br> 2019.04.22提交小修版本,状态直接变为in peer review<br> 2019.07.06 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Sun Jul 07 15:21:58 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851003, encodeId=d6bd851003cf, content=什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Apr 24 12:05:33 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850848, encodeId=ce6a85084877, content=看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Tue Apr 16 18:49:43 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847864, encodeId=428f84e8647a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Oct 25 17:08:11 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2019-04-16 ms8480212230682571

    看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1091652, encodeId=753c1091652ba, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091651, encodeId=6c00109165133, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857043, encodeId=42cc85e04380, content=审稿速度:7.0<br>经验分享:2019.6.8—2019.10.23 一审,major revision;<br> 2019.10.23—2019.11.30 修改论文<br> 2019.11.30—2020.1.2 二审,accepted with mandatory revisions;<br> 2020.1.2—2020.1.7 修改论文;<br> 2020.1.7—2020.1.20 accept.<br> 审稿周期7个月,算是处理比较及时。编辑和审稿人非常专业,小问题提的非常具体。今年升了中科院1区,我想影响力会进一步扩大,审稿也会更加严格。作为老牌顶尖杂志,值得一投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Wed Jan 22 11:41:09 CST 2020, time=2020-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856666, encodeId=a5a88566667c, content=2018年6月投稿;<br> 2019年2月一审意见rq;<br> 2019年4月修回;<br> 2019年8月二审意见rq;<br> 2019年10月修回;<br> 2020年1月三审意见reject。<br> 共历时将近19个月,最终被拒。<br> 审稿人和编辑给了我两次机会,但我的修改却一次不如一次,最终难逃被拒之命运。<br> 伤心的同时,也对该期刊的严谨和认真表示钦佩。<br> 创新性较小的文章不建议投往该期刊,审稿周期很长,被拒了耽误很多时间,划不来。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72665414097, createdName=ms3000046594999774, createdTime=Thu Jan 09 14:07:25 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856182, encodeId=a66d856182b5, content=tip终于上中科院一区了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Wed Dec 25 10:47:37 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855535, encodeId=cc8585553506, content=审稿速度:8.0<br>经验分享:2017.8.25: 投稿<br> 2018.3.27: 一审意见大修。一个大修,三个小修,一个接收;<br> 2018.4.22: 返修提交<br> 2018.8.10: 录用 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Wed Dec 04 15:27:23 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852440, encodeId=6c5985244062, content=审稿速度:12.0<br>经验分享:历时近15个月,中间催稿近10次,今天心终于落地了。<br> 2018.04.16 submitted<br> 2018.05.18 in peer review,区域编辑初审,未分配副主编<br> 2018.06.11 submitted (区域编辑同意送审)<br> 2018.07.02 in peer review,已分配副主编<br> 2018.10.21 awaiting ae decision<br> 2018.10.25 major revision (due 2018.12.05)<br> 2018.12.02提交大修版本,状态直接变为in peer review<br> 2019.04.18 awaiting ae decision<br> 2019.04.18 accept with mandatory minor revisions including english usage (due 2019.05.08)<br> 2019.04.22提交小修版本,状态直接变为in peer review<br> 2019.07.06 accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db1a5414071, createdName=ms1562262113729736, createdTime=Sun Jul 07 15:21:58 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851003, encodeId=d6bd851003cf, content=什么时间给结果真是靠运气,2018.4.16投稿,2018.10.25收到一审意见大修,有一个审稿人一直拖,中间催了3次才给意见,2018.12.2修回,还是那个审稿人拖着一直不给意见,过了四个多月中间催了三次,2019.4.18,ae终于忽略了那个审稿人,仅按照前两个审稿人的意见给了小修,2019.4.22修回,等结果ing~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1265413967, createdName=ms3309476956082021, createdTime=Wed Apr 24 12:05:33 CST 2019, time=2019-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850848, encodeId=ce6a85084877, content=看了好多网友的经验,自己的终于中了。18年7月中旬投稿,19年1月中旬收到大修,五个审稿人,一个问题比较尖锐,质疑创新性,另外一个建议大修,但是基础定义的解释,三个小修。三月中旬改好提交,四月中旬录用。reviewer提的意见都很中肯,做科研这事,还是要一步一个脚印,不能有侥幸心理。祝大家好运! , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Tue Apr 16 18:49:43 CST 2019, time=2019-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847864, encodeId=428f84e8647a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Thu Oct 25 17:08:11 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2018-10-25 ms8472206870533718

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:2018.4.16投稿,2018.10.25才收到一审意见大修,历时半年多,期刊对理论创新和实验充分性要求很高,三个审稿人都给的大修,提出的问题比较专业。之前投tip被拒过一次,平心而论期刊难度还是比较大的,期待这次修改能有个好结果~

    0

共56条页码: 1/6页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map